Low-to-Moderate Dosage and Short-Term Use of Corticosteroids Benefit Patients With Severe COVID-19 Infections

Although the FDA has given emergency use authorization (EUA) for some antiviral drugs for the treatment of COVID-19, no direct antiviral drugs have been identified for the treatment of critically ill patients, the most important treatment is suppression of the hyperinflammation. The purpose of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Liuqing, Peng, Ling, Wu, Weibo, Cao, Mengli, Chen, Chuming, Wang, Fuxiang, Sauver, Jennifer St., Liu, Yingxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343835/
https://www.ncbi.nlm.nih.gov/pubmed/35928154
http://dx.doi.org/10.3389/fmicb.2022.953328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343835/
https://www.ncbi.nlm.nih.gov/pubmed/35928154
http://dx.doi.org/10.3389/fmicb.2022.953328

Ejemplares similares